Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aileen L Pangan

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|April 8, 2017
Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over timeXenofon Baraliakos, Joachim Sieper, Su Chen, et al.
The Journal of Rheumatology|July 4, 2012
Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing SpondylitisWalter P Maksymowych, Robert G Lambert, L Steven Brown, et al.
The Journal of Rheumatology|February 3, 2011
Clinical consequences of delayed addition of adalimumab to methotrexate therapy over 5 years in patients with rheumatoid arthritisEdward C Keystone, Arthur Kavanaugh, Michael E Weinblatt, et al.
The Journal of Rheumatology|September 3, 2018
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and MethotrexateGurjit S Kaeley, Daryl K MacCarter, Aileen L Pangan, et al.
Modern Rheumatology|December 30, 2011
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitisShigeto Kobayashi, Masayoshi Harigai, Neelufar Mozaffarian, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2014
Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritisPhilip Mease, Joachim Sieper, Filip Van den Bosch, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 25, 2014
Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international surveyDésirée van der Heijde, Joachim Sieper, Dirk Elewaut, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitisJoachim Sieper, Désirée van der Heijde, Maxime Dougados, et al.
The Journal of Rheumatology|March 17, 2017
Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with AdalimumabPhilip J Mease, Filip Van den Bosch, Joachim Sieper, et al.
Rheumatology (Oxford, England)|August 29, 2015
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritisDésirée van der Heijde, Avani Joshi, Aileen L Pangan, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|April 8, 2017
Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over timeXenofon Baraliakos, Joachim Sieper, Su Chen, et al.
The Journal of Rheumatology|July 4, 2012
Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing SpondylitisWalter P Maksymowych, Robert G Lambert, L Steven Brown, et al.
The Journal of Rheumatology|February 3, 2011
Clinical consequences of delayed addition of adalimumab to methotrexate therapy over 5 years in patients with rheumatoid arthritisEdward C Keystone, Arthur Kavanaugh, Michael E Weinblatt, et al.
The Journal of Rheumatology|September 3, 2018
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and MethotrexateGurjit S Kaeley, Daryl K MacCarter, Aileen L Pangan, et al.
Modern Rheumatology|December 30, 2011
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitisShigeto Kobayashi, Masayoshi Harigai, Neelufar Mozaffarian, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2014
Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritisPhilip Mease, Joachim Sieper, Filip Van den Bosch, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 25, 2014
Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international surveyDésirée van der Heijde, Joachim Sieper, Dirk Elewaut, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitisJoachim Sieper, Désirée van der Heijde, Maxime Dougados, et al.
The Journal of Rheumatology|March 17, 2017
Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with AdalimumabPhilip J Mease, Filip Van den Bosch, Joachim Sieper, et al.
Rheumatology (Oxford, England)|August 29, 2015
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritisDésirée van der Heijde, Avani Joshi, Aileen L Pangan, et al.
Pageof 5